Skip to main content

Table 3 Characteristics of the studies included in the dose-analysis meta-analysis

From: Prognosis of pregnancy-associated breast cancer: a meta-analysis

Study ID

Time point of breast cancer diagnosis

Time after last delivery

(months)

No. of participants

Adjusted HRa

95% CI

Guinee, 1994 [30]

Postpartum 1–12 m

1–12

40

1.88

0.88–3.98

Postpartum 13–48 m

13–48

51

1.09

0.54–2.19

Postpartum ≥49 m

≥49

35

0.54

0.19–1.55

Olson, 1998 [35]

Postpartum < 24 m

0–24

42

3.1

1.8–5.4

Postpartum ≥24 m

≥24

352

1.3

0.9–2.0

Reeves, 2000 [36]

Postpartum < 60 m

0–60

67

1.56

1.01–2.42

Postpartum 60–108 m

60–108

80

0.88

0.58–1.32

Postpartum > 120 m

> 120

525

0.99

0.77–1.27

Daling, 2002 [38]

Postpartum < 24 m

0–24

83

2.3

1.5–3.4

Postpartum 24–60 m

24–70

120

1.5

1.0–2.1

Postpartum > 60 m

> 70

661

1.2

0.9–1.6

Whiteman, 2004 [42]

Postpartum ≤12 m

0–12

59

1.51

1.02–2.23

Postpartum 13–48 m

13–48

213

1.25

0.95–1.64

Postpartum > 48 m

> 48

1470

1.06

0.86–1.31

Phillips, 2009 [48]

Postpartum < 24 m

0–24

133

2.75

1.98–3.83

Postpartum 24–60 m

24–60

231

2.2

1.65–2.94

Postpartum ≥72 m

≥72

2067

0.98

0.79–1.22

Calliha, 2013 [58]

Postpartum < 60 m

0–60

86

2.65

1.09–6.42

Postpartum ≥60 m

≥60

172

1.52

0.71–3.28

Nagatsuma, 2014 [63]

Postpartum ≤24 m

0–24

37

2.19

1.05–4.56

Postpartum 36–60 m

36–60

59

1.49

0.79–2.83

Postpartum > 60 m

> 60

181

0.81

0.46–1.43

Johansson, 2018 [2]

Postpartum 0–6 m

0–6

41

1.16

0.64–2.14

Postpartum 6–12 m

6–12

84

1.3

0.83–2.03

Postpartum 12–24 m

12–24

194

1.01

0.70–1.46

Postpartum 24–60 m

24–60

629

1.22

0.96–1.55

Postpartum 60–120 m

60–120

1106

1.08

0.87–1.53

Postpartum > 120 m

> 120

1623

0.98

0.78–1.22

Chuang, 2018 [69]

Postpartum 0–12 m

0–12

347

1.29

0.96–1.74

Postpartum 13–24 m

13–24

410

1.27

0.95–1.70

Postpartum 25–60 m

25–60

1583

1.06

0.88–1.27

  1. aCorresponding reference category: nulliparous